By Medinex Specialist Centre Team
Sept 15, 2026
Building a profitable private medical practice in Singapore is a remarkable achievement given the high cost of operation and sti competition. Once your practice reaches stable operational maturity and generates significant free cash flow, a strategic question arises: What is the most effective way to deploy the accumulated profits?
Strategic capital allocation is a defining skill for physician-entrepreneurs. Leaving your excess Strategic capital allocation is a defining skill for physician-entrepreneurs. Leaving your excess retained earnings idle in corporate bank accounts exposes the capital to inflationary erosion while you miss out on growth opportunities. Conversely, hasty deployment without a structured framework can subject your practice to unwarranted risks and result in instability.
As Singapore’s private practice owners, you can generally consider three primary pathways for profit deployment:
• Expanding the core enterprise organically to multi-clinic footprints.
• De-risking and monetising equity through group consolidation and mergers.
• Diversifying into adjacent commercial assets.
Each path carries distinct implications for operational control, equity value, and long-term exit strategy. Let’s explore each option to gain a clearer understanding of the Pros and Cons.
Scaling the existing practice by expanding the number of clinic outlets and recruiting doctors represents a direct growth path. Reinvesting your profits into expanding the physical and clinical footprint leverages your established clinical workflows, patient goodwill, and brand reputation. However, it is important to have a clear idea of how to structure the equity when recruiting new associates to ensure good operational control and business risk management.
A common pitfall in multi-clinic expansion is offering equity prematurely or under terms that dilute operational control. To mitigate equity risk while aligning incentives, you can consider the following two practices:
Tiered Earn-In Models: Instead of granting immediate equity upon recruitment, you can implement a structured 3-to-5-year earn-in timeline where associate doctors can purchase equity at pre-agreed valuation multiples contingent on meeting clinical billing targets, patient retention metrics, and other business or cultural criteria.
Dual-Class Share Structures1–4:
The legislative framework under the Singapore Companies Act 19675 (specifically section 64, as amended by the Companies (Amendment) Act 2014) permits both private and public companies incorporated in Singapore to issue multiple classes of shares with different voting rights (e.g., multiple-vote shares, non-voting shares, or conditional voting shares).
When doing this, you should also seek legal advice to ensure compliance with applicable licensing, governance and regulatory requirements under the Healthcare Services Act6 and any relevant licensing conditions.
As healthcare consolidation accelerates in Southeast Asia, private equity-backed groups and listed medical corporates are actively acquiring independent practices in Singapore. Joining a larger clinic group converts illiquid practice equity into cash and liquid shares while outsourcing administrative overhead. However, you must consider the following before agreeing to an acquisition.
Acquisitions of independent practices are typically structured around enterprise value multiples of Earnings Before Interest, Taxes, Depreciation, and Amortisation (EBITDA):
Valuations are often influenced by factors such as specialty, recurring patient revenue, growth prospects, concentration risk, and the degree of reliance on the founding doctor. Market valuation multiples can vary significantly depending on the circumstances of each transaction.
Cash-Equity Split: Standard deal terms involve an upfront cash payout of 60% to 70%, with the remaining 30% to 40% rolled over into equity in the parent company. This rollover aligns incentives for future exit events (e.g., IPO or secondary buyouts).
Large groups are looking at acquiring patient goodwill and clinical continuity rather than just physical assets. Consequently, the sale terms normally include strict personal service conditions:
Employment Lock-Ins: Expect mandatory 3-to-5-year employment contracts requiring the founding doctor to facilitate a smooth transition.
Non-Compete Restrictive Covenants: Non-Compete Restrictive Covenants: Contracts include geographic and temporal non-compete clauses restricting doctors from practising independently within a specified radius in Singapore for several years post-resignation.
While group integration provides access to corporate insurance panels, group procurement discounts, and centralised HR/HCSA compliance, it may also introduce new cost structures:
Management Service Costs (MSC): Corporate groups typically charge a top-line or overhead management fee (oAten 10% to 20%) to cover centralised overhead.
Margin Impact: Practice owners must evaluate whether economies of scale and increased patient volume oset the management fee’s impact on net operating margins.
For clinic owners looking to build wealth independently of their personal clinical hours, deploying profits into external assets offers a viable pathway to diversify risk.
|
Investment Vehicle
|
Strategic Rationale
|
Key Considerations & Risk Profile
|
|---|---|---|
|
Commercial Medical Real Estate
|
Strata-titled medical suites
(e.g., Novena Medical Centre,
Mount Elizabeth, &
Gleneagles) provide capital
appreciation, rental yield,
and long-term protection
against lease increases.
|
High capital requirements, may take time to find tenants.
|
|
Adjacent Lifestyle
Businesses
|
Medical spas, aesthetic
centres, physiotherapy
practices, and
wellness/longevity centres
|
Creates patient cross-referral
opportunities and leverages
existing brand equity in cash-pay
markets. Requires distinct
management capabilities and
operational oversight, must adhere to Singapore Medical Council (SMC) Ethical Code and Ethical Guidelines⁸ to prevent improper commercial steering.
|
|
HealthTech & Vertical
Integration
|
Diagnostic labs, specialised
medical supply distribution,
or digital health platforms.
|
Provides exposure to scalable
technology and vertical supply
chain eciencies. Higher-risk
profile requiring specialised
venture-building experience
|
Selecting the appropriate capital deployment strategy requires aligning financial resources, personal timeline, and risk tolerance. Whether reinvesting into additional clinics, merging with a corporate group, or purchasing commercial real estate, successful deployment requires disciplined execution, professional tax structuring, and strict legal compliance.
Singapore Companies Act 1967 (Section 64 & Section 64A) — Governs the legal issuance of shares with different voting rights.
SGX Mainboard Rules (Chapter 2 & Part X) — Defines entry criteria, 10:1 voting caps, PHG provisions, and mandatory corporate governance safeguards for DCS companies.
Singapore Exchange (SGX) Rules & Guidelines: Listing Framework for Dual Class Share Structures (effective 26 June 2018).
MoneySense (Monetary Authority of Singapore / SGX): Guide to Shares: Dual-Class Shares.
Singapore Companies Act 1967
Section 39: Effect of constitution (binding contract between members and company).
Section 157: Fiduciary duties and powers of directors.
Section 403(1): Prohibition of payment of dividends except out of profits.
https://www.hcsa.gov.sg/
Singapore Companies (Model Constitutions) Regulations 2015
Model Constitution provision regarding the board’s power to set aside reserves before declaring dividends.
This article is intended for general educational purposes only. As regulatory and business considerations vary depending on individual circumstances, please contact us at contact@medinexsc.com.sg for tailored advice before making any business, investment, or restructuring decisions.
MEDINEX Specialist Centre is an established one-stop consultancy service with more than 20 years of experience helping companies and business owners. We understand the challenges and have the necessary expertise to provide the right solutions to overcome them.
51 Goldhill Plaza #22-03, Singapore 308900. WhatsApp: +65 8023 3505 Email: contact@medinex.com.sg
51 Goldhill Plaza #22-03, Singapore 308900
WhatsApp: +65 8023 3505
Email: contact@medinex.com.sg
© 2026 Medinex Specialist Centre